Skip to main content
. 2020 Feb 24;30(4):756–767. doi: 10.1038/s41370-020-0212-8

Table 3.

Descriptive statistics of urine concentrations.

Compound Year n % >LOD Median P25–P75 P95 Maximum
3-PBA 2000 209 99 0.11 (0.08) 0.06–0.22 (0.05–0.14) 0.62 (0.43) 5.64 (3.43)
2004 197 96 0.10 (0.09) 0.06–0.19 (0.05–0.16) 0.56 (0.50) 3.29 (2.66)
2009 254 100 0.15 (0.12) 0.10–0.30 (0.08–0.24) 1.02 (0.90) 3.68 (2.79)
2013 294 100 0.15 (0.11) 0.08–0.27 (0.06–0.20) 0.79 (0.62) 10.6 (7.89)
2017 195 100 0.21 (0.15) 0.13–0.35 (0.11–0.30) 0.92 (0.65) 18.8 (15.2)
4F-3-PBA 2000 209 63 0.01 (<LOD) <LOD—0.01 (<LOD—0.01) 0.03 (0.03) 0.38 (0.21)
2004 197 54 0.01 (<LOD) <LOD—0.01 (<LOD—0.01) 0.02 (0.02) 0.05 (0.06)
2009 254 74 0.01 (<LOD) <LOD—0.01 (<LOD—0.01) 0.03 (0.03) 0.25 (0.22)
2013 204 62 0.01 (<LOD) <LOD—0.01 (<LOD—0.01) 0.02 (0.02) 0.29 (0.44)
2017 195 42 <LOD (<LOD) <LOD—0.01 (<LOD—0.01) 0.06 (0.04) 0.76 (0.54)
CFCA 2000 209 39 <LOD (<LOD) <LOD—0.01 (<LOD—0.01) 0.05 (0.03) 0.35 (0.18)
2004 197 52 0.01 (0.01) <LOD—0.01 (<LOD—0.01) 0.03 (0.04) 0.09 (0.11)
2009 254 76 0.01 (0.01) <LOD—0.03 (<LOD—0.02) 0.10 (0.07) 1.72 (0.90)
2013 204 86 0.02 (0.02) 0.01–0.04 (0.01–0.03) 0.09 (0.07) 0.38 (0.39)
2017 195 90 0.02 (0.02) 0.01–0.05 (0.01–0.04) 0.40 (0.31) 1.76 (1.20)
DCCA 2000 209 97 0.18 (0.13) 0.11–0.31 (0.08–0.21) 0.78 (0.45) 2.08 (3.09)
2004 197 98 0.18 (0.18) 0.12–0.30 (0.10–0.27) 0.89 (0.86) 8.28 (7.47)
2009 254 99 0.22 (0.16) 0.12–0.34 (0.10–0.25) 0.79 (0.60) 5.35 (3.23)
2013 204 99 0.21 (0.15) 0.13–0.31 (0.10–0.24) 0.63 (0.49) 3.53 (2.06)
2017 195 99 0.16 (0.13) 0.11–0.25 (0.09–0.20) 0.53 (0.41) 0.91 (1.20)
TCPy 2000 209 99 0.82 (0.59) 0.48–1.40 (0.38–0.96) 3.50 (2.38) 12.2 (7.39)
2004 197 99 0.84 (0.80) 0.53–1.60 (0.48–1.47) 4.01 (3.69) 13.9 (10.1)
2009 254 100 1.41 (1.08) 0.85–2.37 (0.68–1.80) 5.21 (3.99) 19.6 (11.4)
2013 204 100 1.11 (0.86) 0.64–2.16 (0.51–1.60) 5.23 (5.06) 43.0 (37.6)
2017 195 99 0.92 (0.70) 0.52–1.74 (0.46–1.36) 6.54 (5.19) 30.1 (16.6)
CCC 2000 196 100 2.98 (2.01) 1.21–8.71 (0.75–6.64) 139 (66.1) 272 (405)
2004 197 100 2.30 (2.09) 1.05–6.88 (6.94–15.5) 16.4 (15.5) 40.9 (40.3)
2009 254 100 3.88 (2.77) 1.28–12.1 (0.89–10.4) 41.5 (30.6) 132 (132)
2013 204 100 1.29 (0.98) 0.59–4.25 (0.41–3.80) 17.1 (16.2) 32.5 (25.1)
2017 196 100 1.17 (0.86) 0.40–3.66 (0.31–3.18) 16.8 (13.6) 49.0 (35.8)
MQ 2000 196 87 0.26 (0.16) 0.04–0.97 (0.03–0.73) 3.80 (2.94) 11.2 (16.6)
2004 197 96 0.64 (0.52) 0.13–2.11 (0.12–2.01) 6.18 (6.40) 14.0 (19.1)
2009 254 97 0.53 (0.33) 0.10–1.56 (0.08–1.21) 6.19 (5.10) 47.3 (42.8)
2013 204 95 0.21 (0.17) 0.07–0.83 (0.05–0.72) 3.75 (3.02) 64.1 (62.5)
2017 196 96 0.37 (0.31) 0.08–1.83 (0.07–1.50) 7.58 (6.02) 58.3 (30.1)
OH-TBZ 2000 209 98 0.05 (0.03) 0.02–0.17 (0.01–0.09) 1.99 (1.91) 17.4 (13.7)
2004 197 95 0.02 (0.02) 0.01–0.08 (0.01–0.08) 0.92 (0.80) 87.1 (53.7)
2009 254 97 0.01 (0.01) 0.01–0.07 (0.00–0.06) 1.60 (1.41) 6.41 (5.20)
2013 204 92 0.02 (0.02) 0.01–0.10 (0.00–0.09) 1.83 (1.27) 17.8 (21.1)
2017 195 94 0.01 (0.09) 0.01–0.04 (0.00–0.03) 0.40 (0.31) 5.37 (4.51)
OH-PYM 2000 209 76 0.02 (0.01) 0.01–0.07 (<LOD—0.05) 0.42 (0.29) 14.3 (8.67)
2004 197 79 0.02 (0.02) 0.01–0.07 (<LOD—0.07) 0.96 (0.96) 10.8 (6.84)
2009 254 88 0.03 (0.02) 0.01–0.20 (0.00–0.15) 1.47 (1.30) 18.2 (22.9)
2013 204 93 0.05 (0.04) 0.01–0.14 (0.01–0.11) 1.63 (1.24) 116 (98.2)
2017 195 99 0.09 (0.07) 0.03–0.24 (0.03–0.21) 18.0 (13.7) 161 (136)
OH-TEB 2000 209 62 0.02 (0.01) <LOD—0.04 (0.01–0.03) 0.31 (0.22) 1.98 (0.68)
2004 197 76 0.04 (0.03) 0.02–0.11 (0.02–0.09) 0.78 (0.85) 2.54 (2.39)
2009 254 93 0.08 (0.06) 0.04–0.14 (0.03–0.10) 0.38 (0.34) 20.5 (12.0)
2013 204 93 0.09 (0.08) 0.05–0.17 (0.04–0.14) 0.90 (0.71) 6.87 (3.66)
2017 195 94 0.12 (0.09) 0.05–0.27 (0.04–0.22) 1.03 (0.86) 12.4 (14.7)
ETU 2000 149 99 0.29 (0.22) 0.14–0.64 (0.10–0.45) 1.68 (1.10) 4.58 (4.40)
2004 196 99 0.40 (0.38) 0.22–0.77 (0.19–0.76) 3.03 (2.87) 5.89 (7–26)
2009 254 99 0.34 (0.26) 0.16–0.68 (0.13–0.52) 2.02 (1.54) 20.0 (8.84)
2013 204 97 0.25 (0.22) 0.12–0.69 (0.09–0.46) 1.60 (1.26) 3.02 (5.23)
2017 196 98 0.18 (0.15) 0.08–0.39 (0.06–0.34) 1.19 (1.02) 7.30 (6.80)
2,4-D 2000 209 65 0.12 (<LOD) <LOD—0.20 (<LOD—0.14) 0.69 (0.48) 2.26 (2.14)
2004 197 58 0.12 (0.11) <LOD—0.21 (<LOD—0.20) 0.44 (0.40) 0.95 (0.82)
2009 254 58 <LOD (<LOD) <LOD—0.15 (<LOD—0.11) 0.35 (0.24) 2.05 (2.13)
2013 204 69 0.13 (0.10) <LOD—0.22 (<LOD—0.17) 0.43 (0.43) 2.24 (0.39)
2017 195 39 <LOD (<LOD) <LOD—0.14 (<LOD—0.11) 0.37 (0.29) 1.64 (1.28)
MCPA 2000 209 72 0.03 (0.02) <LOD—0.05 (<LOD—0.03) 0.12 (0.11) 1.06 (0.56)
2004 197 73 0.03 (0.03) 0.02–0.05 (0.02–0.05) 0.17 (0.14) 0.90 (0.75)
2009 254 69 0.02 (0.02) <LOD—0.04 (<LOD—0.03) 0.14 (0.11) 0.41 (0.40)
2013 204 66 0.02 (0.02) <LOD—0.05 (<LOD—0.04) 0.16 (0.13) 0.63 (0.67)
2017 195 55 0.02 (0.01) <LOD—0.03 (<LOD—0.02) 0.10 (0.07) 1.78 (1.22)

Nonparametric estimates of density-adjusted concentrations in urine samples (µg/L). Creatinine adjusted concentrations are presented in brackets (µg/g creatinine). Detection frequency is reported as percent above limit of detection.